{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:26:46Z","timestamp":1774690006093,"version":"3.50.1"},"reference-count":0,"publisher":"AACN Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:p>A left ventricular assist device (LVAD) is a lifesaving therapy for end-stage heart failure, but it is associated with major complications such as bleeding and thrombosis. Anticoagulation is an important part of LVAD therapy; it requires meticulous management and monitoring for prevention of thromboembolic and bleeding events. Recommendations for thromboprophylaxis vary among pulsatile and nonpulsatile devices and require multiple pharmacological agents to achieve adequate anticoagulation. Patients expected to undergo LVAD implantation must have a comprehensive evaluation for underlying coagulopathies. During the perioperative period, all measures must be taken to prevent excessive bleeding and maintain hemostasis. Postoperative bleeding and thromboembolic episodes must be minimized to prevent significant complications of ventricular assist device therapy. Bleeding and thromboembolism are an impediment to a patient\u2019s quality of life as they can result in multiple hospitalizations, along with serious consequences such as death and permanent disability.<\/jats:p>","DOI":"10.4037\/nci.0b013e31824124d0","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T13:13:41Z","timestamp":1574774021000},"page":"91-98","source":"Crossref","is-referenced-by-count":49,"title":["Anticoagulation and Bleeding in Patients With Ventricular Assist Devices"],"prefix":"10.4037","volume":"23","author":[{"given":"Sudha","family":"Kurien","sequence":"first","affiliation":[{"name":"Sudha Kurien is Ventricular Assist Device Coordinator, Advocate Christ Medical Center, 4400 W 95th St, PO Box 407, Oak Lawn, IL 60453 (). Kylie A. Hughes is Ventricular Assist Device Coordinator, Advocate Christ Medical Center, Oak Lawn, Illinois."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kylie A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Sudha Kurien is Ventricular Assist Device Coordinator, Advocate Christ Medical Center, 4400 W 95th St, PO Box 407, Oak Lawn, IL 60453 (). Kylie A. Hughes is Ventricular Assist Device Coordinator, Advocate Christ Medical Center, Oak Lawn, Illinois."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2471","container-title":["AACN Advanced Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/23\/1\/91\/102604\/01256961-201201000-00013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/23\/1\/91\/102604\/01256961-201201000-00013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T16:20:49Z","timestamp":1574785249000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article\/23\/1\/91\/14571\/Anticoagulation-and-Bleeding-in-Patients-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":0,"aliases":["10.1097\/nci.0b013e31824124d0","10.1097\/nci.0b013e31824124d0"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.4037\/nci.0b013e31824124d0","relation":{},"ISSN":["1559-7768","1559-7776"],"issn-type":[{"value":"1559-7768","type":"print"},{"value":"1559-7776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,1]]}}}